BPCE
MGNX icon

Bank Pictet & Cie (Europe)’s MacroGenics MGNX Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,416
Closed -$242K – 171
2024
Q1 		$242K Buy
+16,416
New +$248K 0.01% 160

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s MGNX Position: Q2 2024 in Review

Bank Pictet & Cie (Europe) sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 16,416 shares — an estimated $242K sold.

Bank Pictet & Cie (Europe) first reported a position in MGNX in Q1 2024 and held it in 1 quarter. The position peaked at $242K in Q1 2024. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

  • Bank Pictet & Cie (Europe) reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 16,416 MacroGenics shares in Q2 2024, an estimated $242K.
  • Bank Pictet & Cie (Europe) first reported a position in MacroGenics in Q1 2024 and held it in 1 quarter.
  • Bank Pictet & Cie (Europe)'s MacroGenics position peaked at $242K in Q1 2024.
  • 146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2024, filed 25 Jul 2024.